by Surgical drapes and gowns are used in hospitals as protective barriers that help prevent surgical site infections. These products are designed to provide an effective microbial barrier between the patient and surgical team. Some key advantages of surgical drapes and gowns include convenience, cost-effectiveness, barrier protection against bodily fluids and infectious microbes. The growing prevalence of hospital-acquired infections and the rise in surgical procedures globally is driving increased demand for these essential protective products. The global surgical drapes and gowns market is estimated to be valued at US$ 3.62 billion in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period from 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the surgical drapes and gowns market is the rise of antimicrobial products. Manufacturers are increasingly developing drapes and gowns coated or impregnated with antimicrobial agents like silver to provide enhanced protection against infection. The antimicrobial properties help inhibit the growth of microbes on the fabric for prolonged duration. Another significant trend is the use of spin bonding technology for manufacturing non-woven fabrics used in surgical drapes and gowns. The spun bond non-woven process produces uniform fabrics with desirable characteristics like strength, barrier protection and absorbency. It has emerged as a cost-effective alternative to conventional manufacturing methods.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the surgical drapes and gowns market is low due to high costs of production and strong presence of established players.
Bargaining power of buyers: The bargaining power of buyers is high as buyers have a good knowledge about products and opt for the low-cost alternatives.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw materials required are available and there are various suppliers in the market.
Threat of new substitutes: The threat of substitutes is low as there are no cost-effective alternatives to surgical drapes and gowns available in the market.
Competitive rivalry: The competitive rivalry in the surgical drapes and gowns market is high. Key players compete on the basis of quality, price, and innovation.
Key Takeaways
The Global Surgical Drapes And Gowns Market Growth is expected to witness high.
Regional analysis: North America dominates the global surgical drapes and gowns market owing to the presence of key players, increasing number of surgical procedures, and growing awareness about hospital-acquired infections in the region. Europe holds the second-largest share of the global market due to increasing volume of surgeries and accessibility of advanced healthcare facilities in the region.
Key players operating in the surgical drapes and gowns market are Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd. Technological advancements and new product launches are the key strategies adopted by major players to gain a competitive edge in the market. For instance, in October 2021, Medline Industries launched Encompass hospital drape and gown system which provides four-way stretch and soft texture to ensure comfort and mobility.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
